Chlorpromazine Recall: AvKare 100 mg
Announced 2026-03-04 · FDA
The FDA lists a recall of AvKARE chlorpromazine hydrochloride tablets, 100 mg, 50-count unit-dose cartons. The recall is due to the presence of a foreign substance and affects 2003 cartons. Lot numbers 47089 (Exp 12/31/25) and 47604 (Exp 03/31/26) are included in the recall.
| Brand | AvKARE |
|---|---|
| Product | chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15 |
| Reason | Presence of a foreign substance. |
| Severity | moderate |
| Units affected | 2003 cartons |
| Distribution | USA Nationwide |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check your packaging for Lot numbers 47089 or 47604 and their expiration dates.
- Do not use the recalled product.
- Visit AvKare’s website for recall instructions and return options.
- If you have used the product, contact your healthcare provider for guidance.
How to identify the recalled item
| Lot / date codes | Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26 |
|---|---|
| Lot / date codes | Lot # 49261, Exp: 04/30/27 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other chlorpromazine recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.